DOI QR코드

DOI QR Code

Equivocal Association of RAD51 Polymorphisms with Risk of Esophageal Squamous Cell Carcinoma in a Chinese Population

  • Zhang, Shu-Xiang (Nursing Department, Shandong Provincial Qianfoshan Hospital) ;
  • Yang, Shan (Department of Ultrasound, Shandong Provincial Qianfoshan Hospital) ;
  • Xu, Chang-Qing (Department of Gastroenterology, Shandong Provincial Qianfoshan Hospital) ;
  • Hou, Rui-Ping (Department of Gastroenterology, Shandong Provincial Qianfoshan Hospital) ;
  • Zhang, Chuan-Zhen (Department of Gastroenterology, Shandong Provincial Qianfoshan Hospital) ;
  • Xu, Cui-Ping (Department of Human Resources, Shandong Provincial Qianfoshan Hospital)
  • Published : 2014.01.30

Abstract

Aim: To study the contribution of genetic variation in RAD51 to risk of esophageal squamous cell carcinoma (ESCC). Methods: Three single nucleotide polymorphisms (SNPs) in RAD51 (rs1801320, rs4144242 and rs4417527) were genotyped in 316 ESCC patients and 316 healthy controls in Anyang area of China using PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism). Demographic variables between cases and controls were statistically compared by T test and Chi-square test. Hardy-Weinberg equilibrium was evaluated by the Chi-square test. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to measure any association with ESCC. Haplotype frequencies were estimated by Phase 2.1. Result: The genotype frequencies of rs1801320, rs4144242 and rs4417527 in patients with ESCC demonstrated no significant differences from those in control group (P>0.05). When the haplotypes of these three SNPs were constructed and their relationships with ESCC risk investigated, however, CGG was observed to increase the risk (P=0.020, OR=2.289). Conclusions: There was no association between the three SNPs of RAD51 and ESCC susceptibility in our Chinese population. However, the CGG haplotype might be a risk factor.

Keywords

References

  1. Cheng XL, Ning T, Xu CQ, et al (2011). Haplotype analysis of CTLA4 gene and risk of esophageal squamous cell carcinoma in Anyang area of China. Hepatogastroenterology, 58, 432-7.
  2. Gresner P, Gromadzinska J, Polanska K, et al (2012). Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer. Gene, 504, 166-74. https://doi.org/10.1016/j.gene.2012.05.030
  3. Humar B, Graziano F, Cascinu S, et al (2002). Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene, 21, 8192-5. https://doi.org/10.1038/sj.onc.1205921
  4. Khanna KK, Jackson SP (2001). DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet, 27, 247-54. https://doi.org/10.1038/85798
  5. Kollarova H, Machova L, Horakova D, Janoutova G, Janout V (2007). Epidemiology of esophageal cancer--an overview article. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 151, 17-20. https://doi.org/10.5507/bp.2007.003
  6. Krupa R, Sliwinski T, Wisniewska-Jarosinska M, et al (2011). Polymorphisms in RAD51, XRCC2 and XRCC3 gene of the homologous recombination repair in colorectalcancer-a case control study. Mol Biol Rep, 38, 2849-54. https://doi.org/10.1007/s11033-010-0430-6
  7. Lim DS, Hasty P (1996). A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol Cell Biol, 16, 7133-43.
  8. Lu J, Wang LE, Xiong P, et al (2007). 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis, 28, 988-94.
  9. Nogueira A, Catarino R, Faustino I, et al (2012). Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy. Gene, 504, 279-83. https://doi.org/10.1016/j.gene.2012.05.037
  10. O'Driscoll M, Jeggo PA (2006). The role of double-strand break repair - insights from human genetics. Nat Rev Genet, 7, 45-54.
  11. Paques F, Haber JE (1999). Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev, 63, 349-404.
  12. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  13. Pasaje CF, Kim JH, Park BL, et al (2011). Lack of association of RAD51 genetic variations with hepatitis B virus clearance and occurrence of hepatocellular carcinoma in a Korean population. J Med Virol, 83, 1892-9. https://doi.org/10.1002/jmv.22122
  14. Poplawski T, Arabski M, Kozirowska D, et al (2006). DNA damage and repair in gastric cancer--a correlation with the hOGG1 and RAD51 genes polymorphisms. Mutat Res, 601, 83-91. https://doi.org/10.1016/j.mrfmmm.2006.06.002
  15. Roberts-Thomson IC, Butler WJ (2005). Polymorphism and squamous cell cancer of the esophagus. J Gastroenterol Hepatol, 20, 486-7. https://doi.org/10.1111/j.1440-1746.2005.03821.x
  16. Romanowicz-Makowska H, Smolarz B, Zadrozny M, et al (2011). Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med, 224, 201-8. https://doi.org/10.1620/tjem.224.201
  17. Schild D, Wiese C (2010). Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability. Nucleic Acids Res, 38, 1061-1070. https://doi.org/10.1093/nar/gkp1063
  18. Shrivastav M, De Haro LP, Nickoloff JA (2008). Regulation of DNA double-strand break repair pathway choice. Cell Res, 18, 134-47. https://doi.org/10.1038/cr.2007.111
  19. Shrivastav M, De Haro LP, Nickoloff JA (2008). Regulation of DNA double-strand break repair pathway choice. Cell Res, 18, 134-47. https://doi.org/10.1038/cr.2007.111
  20. Shrivastav M, De Haro LP, Nickoloff JA (2008). Regulation of DNA double-strand break repair pathway choice. Cell Res, 18, 134-47. https://doi.org/10.1038/cr.2007.111
  21. Sliwinski T, Walczak A, Przybylowska K, et al (2010). Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp Mol Pathol, 89, 358-66. https://doi.org/10.1016/j.yexmp.2010.08.005
  22. Sonoda E, Sasaki MS, Buerstedde JM, et al (1998). Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J, 17, 598-608. https://doi.org/10.1093/emboj/17.2.598
  23. Thacker J (2005). The RAD51 gene family, genetic instability and cancer. Cancer Lett, 219, 125-35. https://doi.org/10.1016/j.canlet.2004.08.018
  24. Tsuzuki T, Fujii Y, Sakumi K, et al (1996). Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci USA, 93, 6236-40. https://doi.org/10.1073/pnas.93.13.6236
  25. West SC (2003). Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol, 4, 435-45. https://doi.org/10.1038/nrm1127

Cited by

  1. Upregulation of STK15 in Esophageal Squamous Cell Carcinomas in a Mongolian Population vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6021
  2. Correlation between Selected XRCC2, XRCC3 and RAD51 Gene Polymorphisms and Primary Breast Cancer in Women in Pakistan vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10225
  3. Association of RAD 51 135 G/C, 172 G/T and XRCC3 Thr241Met Gene Polymorphisms with Increased Risk of Head and Neck Cancer vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10457
  4. in oral and oropharyngeal carcinomas pp.1354523X, 2019, https://doi.org/10.1111/odi.12943